Ralph Bennett, MD
Rheumatology · Mesa, AZNPI 1366433161
Payments from drug & device makers
Across 1,207 payments — averaging $1044.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$370K
- Amgen$245K
- UCB SA$244K
- AbbVie$149K
- Janssen Research & Development, LLC$148K
- Astrazeneca UK Limited$43K
- plus $61K from 30 others
Across 8 payments — averaging $164.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 149 | $370,395 |
| Amgen(2 entities) | 253 | $245,309 |
| UCB SA | 58 | $244,117 |
| AbbVie | 307 | $149,493 |
| Janssen Research & Development, LLC | 47 | $148,362 |
| Astrazeneca UK Limited | 7 | $42,685 |
| Genentech, Inc. | 3 | $28,300 |
| Gilead | 3 | $20,323 |
| E.r. Squibb & Sons, L.L.C. | 29 | $6,397 |
| Pfizer | 102 | $1,424 |
| UCB, Inc. | 43 | $772 |
| Novartis | 34 | $653 |
| Johnson & Johnson(2 entities) | 34 | $488 |
| Lilly USA, LLC | 26 | $451 |
| Genentech USA, Inc. | 32 | $436 |
| AstraZeneca(2 entities) | 10 | $268 |
| Sanofi | 13 | $258 |
| Mallinckrodt Hospital Products Inc. | 6 | $151 |
| Organon | 9 | $129 |
| Radius Health, Inc. | 5 | $105 |
| Pacira Therapeutics, Inc. | 5 | $83 |
| Bristol Myers Squibb | 5 | $83 |
| Aurinia Pharma U.S., Inc. | 5 | $81 |
| Boehringer Ingelheim | 3 | $77 |
| Mallinckrodt Enterprises LLC | 3 | $75 |
| Hikma Pharmaceuticals USA | 5 | $65 |
| Merck | 2 | $30 |
| Fidia Pharma USA Inc. | 1 | $29 |
| Bioventus LLC | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $25 |
| Abbott | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $13 |
| Sobi, Inc | 1 | $11 |
How this compares
$1,261,190 in reported general payments places this provider in the 85th percentile of 102 rheumatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Mesa
- Areena SwarupMesa$2.6M
- Debra MichelMesa$4K
- Mona AminGlendale$5.5M
- Nehad SolomanPhoenix$4.8M
- John TesserPhoenix$4.8M
- Joon Hee LimGilbert$4.5M
- Andrew SharobeemGlendale$4M
- Swati BharadwajPhoenix$3.4M
- Amer Al-KhoudariChandler$3.3M
- Rajat DharGlendale$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.